Bhaskar Anand - 12 Jan 2025 Form 4 Insider Report for Summit Therapeutics Inc. (SMMT)

Role
Chief Accounting Officer
Signature
/s/ Bhaskar Anand
Issuer symbol
SMMT
Transactions as of
12 Jan 2025
Transactions value $
$0
Form type
4
Date filed
14 Jan 2025, 16:06
Previous filing
13 Sep 2024
Next filing
01 May 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SMMT Stock Option (right to buy) Award +75K 75K 12 Jan 2025 Common Stock 75K $17.85 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on January 12, 2025. The shares underlying the option shall vest in four equal annual installments, with the first such installment occurring on January 12, 2026.
F2 Not Applicable.